Dr. Ghulam Jilany Khan

Dr. Ghulam Jilany Khan

Dr. Ghulam Jilany Khan

Associate Professor

Ghulam.jilany@ucp.edu.pk
Ext: 251

Dr. Ghulam Jilany Khan has strong ambitions to serve the academia using all the knowledge and skills in academics via both theoretical and practical approach. He is very much determined to bring novel health care findings and ideas at practical and clinical level to enhance the health and educational standards of Pakistan. Presently he is working as Associate Professor of Pharmacology with core responsibilities to teach the subject of Pharmacology and Clinical Pharmacy to the students of Pharm. D and M. Phil as full time regular faculty member of University of Central Punjab and HEC approved Ph. D supervisor in the field of Medical Sciences. Being proficient in health care marketing, he also teaches a full module of pharmaceutical marketing to outgoing final year batch of Pharm. D. Besides the academics, based on his technical and administrative capabilities, he is also serving as focal person of Pharm. D admission committee; Coordinator of Curricula review committee; core focal person for Pharm. D accreditation and renewal with Pharmacy Council of Pakistan (PCP) and other governing bodies; head incharge of Pharmacology section at FOP, UCP. Dr. Khan is devotedly involved in multiple research projects and has more than 65 scientific publication to his credit. His total impact factors is more than 180 with h-index of 19, i-10 index of 33 and more than 1750 citations/mentions (academia.edu). In addition to that he has also served as the editor of “Journal of international medical research” (impact factor: 1.32), editorial board member of many international journals as well as the Web of Science/Pubmed central database (Publon) verified reviewer of several research journals where he is ranked within top 5 percentile all over the globe in the field of Pharmacology since beginning and among top 1% within year 2019-2021 (Publon/web of science database).

PGD Clinical Pharmacy (Pharmacology) Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Canada 2017
Ph. D Pharmacology School of Pharmacy, China Pharmaceutical University, Nanjing, P. R. China 2014-2017
M. Phil Pharmacology and Toxicology University of Veterinary and Animal Sciences, Lahore, Pakistan 2010-2012
MBA Healthcare Marketing University of Veterinary and Animal Sciences, Lahore, Pakistan 2008-2010
Pharm. D Pharmacy (Degree Upgradation) University college of Pharmacy, University of The Punjab, Lahore, Pakistan 2007-2008
B. Pharmacy Pharmacy University college of Pharmacy, University of The Punjab, Lahore, Pakistan2006
Associate Professor of Pharmacology (Section in-charge) Faculty of Pharmacy, University of Central Punjab, Lahore, Pakistan 2020 till date
Assistant Professor Faculty of Pharmacy, University of Central Punjab, Lahore, Pakistan 2018-2020
Lecturer Faculty of Pharmacy, University of Central Punjab, Lahore, Pakistan2013-2018
Pharmacy Manager New Mehmood Pharmacy 2012-2013
Lecturer/Campus Coordinator AIHS, UHS Lahore 2010-2012
Chief Pharmacist CPMC teaching Hospital, Kasur 2009-2010
Branch Pharmacist/Shift In-charge Fazal Din’s Pharma Plus, Lahore 2007-2009
1"Ginsenoside Rg1 ameliorates blood–brain barrier disruption and traumatic brain injury via attenuating macrophages derived exosomes miR-21 release." Acta Pharmaceutica Sinica B 11(11): 3493-3507. I. F=14.903
2"Computational pharmacology and bioinformatics to explore the potential mechanism of Schisandra against atherosclerosis." Food and Chemical Toxicology 150: 112058. I. F=5.572
3"Identification of phytochemicals and antioxidant activity of Premna microphylla Turcz. stem through UPLC-LTQ-Orbitrap-MS." Food Chemistry 373: 131482. I. F=9.231
4"Identification and characterization of potential antioxidant components in Isodon amethystoides (Benth.) Hara tea leaves by UPLC-LTQ-Orbitrap-MS." Food and Chemical Toxicology 148: 111961. I. F=5.572
5 "Pharmacological effects and potential therapeutic targets of DT-13." Biomedicine & Pharmacotherapy 97: 255-263. I. F=7.419
6"In-vitro pre-treatment of cancer cells with TGF-β1: a novel approach of tail vein lung cancer metastasis mouse model for anti-metastatic studies." Current Molecular Pharmacology 12(4): 249-260. I. F=3.34
7"Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases." Drug Discovery Today 24(1): 112-128. I. F= 8.369
8"Frequency of Thalassemia and Its Association with Hepatitis C Infection in Local Population of Pakistan." Biomedica 36(3).
9"IDH mutations associated impact on related cancer epidemiology and subsequent effect towards HIF-1α." Biomedicine & Pharmacotherapy 89: 805-811. I. F=7.419

Girls Hostel Datesheets Merit List Apply Online
X